Immunogenicity and safety of a live-attenuated SARS-CoV-2 vaccine candidate based on multiple attenuation mechanismsMie Suzuki-Okutani, Hirotaka Ebina|eLife|2024Cited by 1
Immunogenicity and safety of a live-attenuated SARS-CoV-2 vaccine candidate based on multiple attenuation mechanismsMie Suzuki-Okutani, Hirotaka Ebina|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 0